BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2021 8:24:11 AM | Browse: 415 | Download: 1247
 |
Received |
|
2021-03-13 16:42 |
|
Peer-Review Started |
|
2021-02-19 09:13 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-04 16:07 |
|
Revised |
|
2021-04-17 02:19 |
|
Second Decision |
|
2021-05-24 06:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-24 10:23 |
|
Articles in Press |
|
2021-05-24 10:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-06-06 08:48 |
|
Typeset the Manuscript |
|
2021-07-12 17:02 |
|
Publish the Manuscript Online |
|
2021-07-21 08:24 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Relapsed/refractory classical Hodgkin lymphoma effectively treated by combination low-dose decitabine plus tislelizumab: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiao-Sheng Ding, Lan Mi, Yu-Qin Song, Wei-Ping Liu, Hui Yu, Ning-Jing Lin and Jun Zhu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jun Zhu, MD, PhD, Chief Doctor, Doctor, Doctor, Professor, Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing 100142, China. zhu-jun2017@outlook.com |
| Key Words |
Immunotherapy; Hypomethylating agent; Classical Hodgkin lymphoma; Survival; Case report |
| Core Tip |
We report a 27-year-old man who complained of enlarged right-sided cervical lymph nodes and progressive pain aggravation of the right shoulder over the past 3 mo before admission. Histological analysis of lymph node biopsy was suggestive of classical Hodgkin’s lymphoma. The patient experienced failure of eight lines of therapy. Computed tomography showed that the tumors of the chest and abdomen significantly shrunk or disappeared after 3 cycles of treatment. The patient has been followed up for 11.5 mo until now, and no progressive enlargement of the tumor has been observed. |
| Publish Date |
2021-07-21 08:24 |
| Citation |
Ding XS, Mi L, Song YQ, Liu WP, Yu H, Lin NJ, Zhu J. Relapsed/refractory classical Hodgkin lymphoma effectively treated by combination low-dose decitabine plus tislelizumab: A case report. World J Clin Cases 2021; 9(21): 6041-6048 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i21/6041.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i21.6041 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
